Stemtech Corporation (STEK)

Stemtech Corporation (STEK): revenue, margins and EPS from its SEC filings, and Graham's reads as they come out.

Reads

• Stemtech Corp reports a going-concern warning in its third-quarter filing amid a $10.7 million working capital deficit and falling sales. Dodd · STEK

From its filings

• Quarter ending 2026-09-30: revenue $282K (-66.9% vs a year earlier) · operating margin -131.5% · EPS 0.00 · filed 2026-11-13
• Quarter ending 2026-06-30: revenue $629K (-9.8% vs a year earlier) · operating margin -20.0% · EPS 0.00 · filed 2026-08-14
• Quarter ending 2026-03-31: revenue $463K (-46.7% vs a year earlier) · operating margin -236.4% · EPS 0.00 · filed 2026-06-22
• Quarter ending 2025-12-31: revenue $458K (-65.1% vs a year earlier) · operating margin -188.6% · EPS 0.00 · filed 2026-05-29
• Quarter ending 2025-09-30: revenue $852K (-17.4% vs a year earlier) · operating margin -39.8% · EPS -0.01 · filed 2026-11-13
• Quarter ending 2025-06-30: revenue $698K (-47.4% vs a year earlier) · operating margin -43.1% · EPS 0.00 · filed 2026-08-14
• Quarter ending 2025-03-31: revenue $868K (-37.2% vs a year earlier) · operating margin -138.8% · EPS -0.01 · filed 2026-06-22
• Quarter ending 2024-12-31: revenue $1.3M (-3.5% vs a year earlier) · operating margin 2.5% · EPS 0.01 · filed 2026-05-29

Source: SEC EDGAR, 10-Q/10-K, as filed.